Angiogenesis
Research Areas
Products Related to Angiogenesis(378)
- GC74401cRGDfK-thioacetyl ester TFAPurity: >99.00%
cRGDfK-thioacetyl ester TFA 는 생물 활성 폴리펩티드 분자의 일종이다.cRGDfK 펩타이드는 통합소에 대해 선택적 친화력을 가진다.cRGDfK 펩타이드는 암 표적 이미징에 사용되는 NIR 형광 프로브를 수정할 수 있습니다.
- GC747102-Methylbutyrylcarnitine chloridePurity: >98.00%
2-Methylbutyrylcarnitine chloride 는 혈소판의 통합소인 알파2베타1과 결합하여 세포질인지효소인 A2(cPLA2)의 활성화와 혈소판의 과잉반응성을 강화하는 장내 미생물 대사산물이다.
- GC79131FurtisetabartCAS: 3055975-56-6Purity: >99.00%
Furtisetabart is a humanized monoclonal antibody targeting CD147 with anti-tumor activity.
- GC79132Fibronectin sctive fragment control acetatePurity: >99.00%
Fibronectin active fragment control acetate is an active peptide fragment of fibronectin.
- GC79133α4β7 Integrin-IN-2CAS: 2640360-68-3Purity: >98.00%
α4β7 Integrin-IN-2 is an inhibitor of human α4β7 integrin with an IC 50 <5 nM.
- GC79136Deethyl-emvistegrast TFAPurity: >98.50%
Deethyl-emvistegrast TFA is a quinoline derivative and also a α4β7 integrin inhibitor.
- GC79137C16Y acetatePurity: >98.50%
C16Y acetate is a short peptide and an inhibitor of integrins αvβ3 and α5β1.
- GC79140Cyclo(-RGDfK), 5/6 FAM labeled TFAPurity: >98.00%
Cyclo(-RGDfK), 5/6 FAM labeled TFA is a Cyclo(-RGDfK) TFA labeled with 5/6 FAM.
- GC79141T7 Peptide TFAPurity: >98.00%
T7 Peptide TFA is a protein synthesis inhibitor and anti-angiogenic agent, with a K d of 10 nM for human transferrin receptor.
- GC79669PHD-1-IN-4CAS: 2009343-19-3Purity: >99.50%
PHD-1-IN-4 is a brain-penetrant PHD-1 inhibitor with an IC 50 of 0.074 μM [1] .
- GC79816CryptolepineCAS: 480-26-2Purity: >98%
Cryptolepine is an orally active multi-potent alkaloid with anti-cancer, anti-bacterial, anti-viral, anti-malarial, anti-inflammatory, anti-hyperglycemic, relieve pain and other properties.
- GC79995(S,R)-EmvistegrastCAS: 2417307-56-1Purity: >98%
(S,R)-Emvistegrast ((S,R)-GS-1427) is an isomer of Emvistegrast.
- GC80856(R,R)-BexobrutidegCAS: 2649400-33-7Purity: >98.50%
(R,R)-Bexobrutideg is the (R,R)-enantiomer of Bexobrutideg.
- GC81027PROTAC HIF-1α degrader-2CAS: 3095636-64-6Purity: >98%
PROTAC HIF-1α degrader-2 is a highly efficient and selective PROTAC degrader targeting HIF-1α. PROTAC HIF-1α degrader-2 promotes HIF-1α degradation via the ubiquitin-proteasome pathway by facilitating the formation of a HIF-1α/VHL ternary complex.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC74401 | cRGDfK-thioacetyl ester TFA | - | >99.00% | |
cRGDfK-thioacetyl ester TFA 는 생물 활성 폴리펩티드 분자의 일종이다.cRGDfK 펩타이드는 통합소에 대해 선택적 친화력을 가진다.cRGDfK 펩타이드는 암 표적 이미징에 사용되는 NIR 형광 프로브를 수정할 수 있습니다. | ||||
| GC74470 | Veltuzumab | 728917-18-8 | >99.00% | |
Veltuzumab (IMMU-106)은 인간화된 항 cd20단일클론 항체이다. | ||||
| GC74710 | 2-Methylbutyrylcarnitine chloride | - | >98.00% | |
2-Methylbutyrylcarnitine chloride 는 혈소판의 통합소인 알파2베타1과 결합하여 세포질인지효소인 A2(cPLA2)의 활성화와 혈소판의 과잉반응성을 강화하는 장내 미생물 대사산물이다. | ||||
| GC78962 | MS1129 | - | >98% | |
MS1129 is a DNMT degrader that induces proteasomal degradation of DNMT1, DNMT3A and DNMT3B proteins. | ||||
| GC79131 | Furtisetabart | 3055975-56-6 | >99.00% | |
Furtisetabart is a humanized monoclonal antibody targeting CD147 with anti-tumor activity. | ||||
| GC79132 | Fibronectin sctive fragment control acetate | - | >99.00% | |
Fibronectin active fragment control acetate is an active peptide fragment of fibronectin. | ||||
| GC79133 | α4β7 Integrin-IN-2 | 2640360-68-3 | >98.00% | |
α4β7 Integrin-IN-2 is an inhibitor of human α4β7 integrin with an IC 50 <5 nM. | ||||
| GC79134 | GREDVGC | 1810716-06-3 | >99.00% | |
GREDVGC is a peptide. | ||||
| GC79135 | c-RGD-SH TFA | - | >98.50% | |
c-RGD-SH TFA is an Integrin αvβ3 ligand. | ||||
| GC79136 | Deethyl-emvistegrast TFA | - | >98.50% | |
Deethyl-emvistegrast TFA is a quinoline derivative and also a α4β7 integrin inhibitor. | ||||
| GC79137 | C16Y acetate | - | >98.50% | |
C16Y acetate is a short peptide and an inhibitor of integrins αvβ3 and α5β1. | ||||
| GC79140 | Cyclo(-RGDfK), 5/6 FAM labeled TFA | - | >98.00% | |
Cyclo(-RGDfK), 5/6 FAM labeled TFA is a Cyclo(-RGDfK) TFA labeled with 5/6 FAM. | ||||
| GC79141 | T7 Peptide TFA | - | >98.00% | |
T7 Peptide TFA is a protein synthesis inhibitor and anti-angiogenic agent, with a K d of 10 nM for human transferrin receptor. | ||||
| GC79574 | mCPX | 1351572-56-9 | >98% | |
mCPX is a prodrug of the antifungal agent Ciclopirox olamine (CPX). | ||||
| GC79669 | PHD-1-IN-4 | 2009343-19-3 | >99.50% | |
PHD-1-IN-4 is a brain-penetrant PHD-1 inhibitor with an IC 50 of 0.074 μM [1] . | ||||
| GC79670 | ZG-2686 | 1795110-22-3 | >98% | |
ZG-2686 is a potent and selective HIF-2α agonist with an EC 50 of 0.25 µM. | ||||
| GC79671 | HIF-IN-2 | 1040535-05-4 | >95.00% | |
HIF-IN-2 is a HIF/HIF prolyl hydroxylase inhibitor. | ||||
| GC79816 | Cryptolepine | 480-26-2 | >98% | |
Cryptolepine is an orally active multi-potent alkaloid with anti-cancer, anti-bacterial, anti-viral, anti-malarial, anti-inflammatory, anti-hyperglycemic, relieve pain and other properties. | ||||
| GC79995 | (S,R)-Emvistegrast | 2417307-56-1 | >98% | |
(S,R)-Emvistegrast ((S,R)-GS-1427) is an isomer of Emvistegrast. | ||||
| GC80483 | IOX2-NH2 | 931400-77-0 | >98.00% | |
IOX2 -NH2 (example 115) is a derivative of IOX2. | ||||
| GC80856 | (R,R)-Bexobrutideg | 2649400-33-7 | >98.50% | |
(R,R)-Bexobrutideg is the (R,R)-enantiomer of Bexobrutideg. | ||||
| GC80928 | NP1192 | 2966791-41-1 | >99.00% | |
NP1192 is a potent, selective PROTAC NAT10 degrader. | ||||
| GC81027 | PROTAC HIF-1α degrader-2 | 3095636-64-6 | >98% | |
PROTAC HIF-1α degrader-2 is a highly efficient and selective PROTAC degrader targeting HIF-1α. PROTAC HIF-1α degrader-2 promotes HIF-1α degradation via the ubiquitin-proteasome pathway by facilitating the formation of a HIF-1α/VHL ternary complex. | ||||
| GC81031 | NEO-811 | 3084635-77-5 | >98% | |
NEO-811 is a selective and orally active ARNT (HIF-1β) molecular glue degrader. | ||||